Overview
Efficacy and Safety of Nitazoxanide in preventing recurrence of Hepatic Encephalopathy.
Description
Clinical Study Evaluating the Efficacy and Safety of Nitazoxanide in preventing recurrence of Hepatic Encephalopathy.
Eligibility
Inclusion Criteria:
- Cirrhotic patient with at least one previous episode of hepatic encephalopathy.
- Adult Patients aging from 20 to 65 years old
Exclusion Criteria:
- Active GIT bleeding.
- Major psychiatric illness (psychosis & epilepsy).
- Renal insufficiency (S.Cr 2mg/dl).